About
7.07USD+0.05 +0.71%
Closed • Updated at 22:08 GMT+00:00Market Cap$696.04M
Volume727.9K
Beta0.83
RSI49.16
Solid Biosciences Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 12 2026
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates
May 7 2026
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
Apr 30 2026
Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy
Apr 28 2026
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
Mar 19 2026
Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Recent Videos

Solid Biosciences: A Game Changer in Gene Therapy? #GeneTherapy #SolidBiosciences #Biotech
Apr 14, 2026

SLDB STOCK : MAJOR UPSIDE | SOLID BIOSCIENCES STOCK
Apr 08, 2026

Solid Biosciences is working on a microdystrophin gene therapy. What exactly is that?
Mar 26, 2026

Solid Biosciences Inc. 2025 annual report
Mar 21, 2026
Community Chat
Ask AI
Try asking
Google Übersetzer